Skip to main content
Log in

Stem cell regeneration of degenerated intervertebral discs: Current status

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Low back pain (LBP) is one of the most common musculoskeletal conditions, and intervertebral disc (IVD) degeneration is associated with most cases. Although many treatment options are available, they focus on the removal of symptoms rather than repair of the degenerate tissue. However, there is a growing interest in the potential of cell-based tissue engineering strategies for regeneration of the damaged IVD. To achieve this, investigators are now focusing on the use of mesenchymal stem cells (MSCs), which offer several advantages over more mature cell types. A number of problems must be overcome for MSC-based IVD regeneration to be successful, including determining a method for the differentiation of stem cells into nucleus pulposus-like cells. Although this is still a relatively new field, it offers huge potential for the clinical treatment of IVD degeneration and LBP in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Stewart WF, Ricci JA, Chee E, et al.: Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003, 290:2443–2454.

    Article  CAS  PubMed  Google Scholar 

  2. Walker BF: The prevalence of low back pain: a systematic review of the literature from 1966 to 1998. J Spinal Disord 2000, 13:205–217.

    Article  CAS  PubMed  Google Scholar 

  3. Papageorgiou AC, Croft PR, Ferry S, et al.: Estimating the prevalence of low back pain in the general population. Evidence from the South Manchester Back Pain Survey. Spine 1995, 20:1889–1894.

    Article  CAS  PubMed  Google Scholar 

  4. Jones GT, Johnson RE, Wiles NJ, et al.: Predicting persistent disabling low back pain in general practice: a prospective cohort study. Br J Gen Pract 2006, 56:334–341.

    PubMed  Google Scholar 

  5. Harkness EF, Macfarlane GJ, Silman AJ, McBeth J: Is musculoskeletal pain more common now than 40 years ago?: Two population-based cross-sectional studies. Rheumatology (Oxford) 2005, 44:890–895.

    Article  CAS  Google Scholar 

  6. Maniadakis N, Gray A: The economic burden of back pain in the UK. Pain 2000, 84:95–103.

    Article  CAS  PubMed  Google Scholar 

  7. Andersson GB: Epidemiological features of chronic low-back pain. Lancet 1999, 354:581–585.

    Article  CAS  PubMed  Google Scholar 

  8. Nelemans PJ, deBie RA, deVet HC, Sturmans F: Injection therapy for subacute and chronic benign low back pain. Spine 2001, 26:501–515.

    Article  CAS  PubMed  Google Scholar 

  9. Fritzell P, Hagg O, Wessberg P, Nordwall A: 2001 Volvo Award Winner in Clinical Studies: Lumbar fusion versus nonsurgical treatment for chronic low back pain: a multicenter randomized controlled trial from the Swedish Lumbar Spine Study Group. Spine 2001, 26:2521–2532.

    Article  CAS  PubMed  Google Scholar 

  10. Fairbank J, Frost H, Wilson-MacDonald J, et al.: Randomised controlled trial to compare surgical stabilisation of the lumbar spine with an intensive rehabilitation programme for patients with chronic low back pain: the MRC spine stabilisation trial. BMJ 2005, 330:1233.

    Article  PubMed  Google Scholar 

  11. Levin DA, Hale JJ, Bendo JA: Adjacent segment degeneration following spinal fusion for degenerative disc disease. Bull NYU Hosp Jt Dis 2007, 65:29–36.

    PubMed  Google Scholar 

  12. Blumenthal S, McAfee PC, Guyer RD, et al.: A prospective, randomized, multicenter Food and Drug Administration investigational device exemptions study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part I: evaluation of clinical outcomes. Spine 2005, 30:1565–1575.

    Article  PubMed  Google Scholar 

  13. Bertagnoli R, Yue JJ, Shah RV, et al.: The treatment of disabling single-level lumbar discogenic low back pain with total disc arthroplasty utilizing the Prodisc prosthesis: a prospective study with 2-year minimum follow-up. Spine 2005, 30:2230–2236.

    Article  PubMed  Google Scholar 

  14. Di Martino A, Vaccaro AR, Lee JY, et al.: Nucleus pulposus replacement: basic science and indications for clinical use. Spine 2005, 30:S16–S22.

    Article  PubMed  Google Scholar 

  15. Sive JI, Baird P, Jeziorsk M, et al.: Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol 2002, 55:91–97.

    Article  CAS  PubMed  Google Scholar 

  16. Mwale F, Roughley P, Antoniou J: Distinction between the extracellular matrix of the nucleus pulposus and hyaline cartilage: a requisite for tissue engineering of intervertebral disc. Eur Cell Mater 2004, 8:58–63.

    CAS  PubMed  Google Scholar 

  17. Zhao CQ, Jiang LS, Dai LY: Programmed cell death in intervertebral disc degeneration. Apoptosis 2006, 11:2079–2088.

    Article  PubMed  Google Scholar 

  18. Le Maitre CL, Freemont AJ, Hoyland JA: Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther 2007, 9:R45.

    Article  PubMed  Google Scholar 

  19. Le Maitre CL, Freemont AJ, Hoyland JA: Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol 2004, 204:47–54.

    Article  PubMed  Google Scholar 

  20. Le Maitre CL, Hoyland JA, Freemont AJ: Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study. Arthritis Res Ther 2007, 9:R83.

    Article  PubMed  Google Scholar 

  21. Masuda K, Imai Y, Okuma M, et al.: Osteogenic protein-1 injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit anular puncture model. Spine 2006, 31:742–754.

    Article  PubMed  Google Scholar 

  22. Li X, Leo BM, Beck G, et al.: Collagen and proteoglycan abnormalities in the GDF-5-deficient mice and molecular changes when treating disk cells with recombinant growth factor. Spine 2004, 29:2229–2234.

    Article  PubMed  Google Scholar 

  23. Yoon ST, Park JS, Kim KS, et al.: ISSLS prize winner: LMP-1 upregulates intervertebral disc cell production of proteoglycans and BMPs in vitro and in vivo. Spine 2004, 29:2603–2611.

    Article  PubMed  Google Scholar 

  24. Jones DG, Peterson L.: Autologous chondrocyte implantation. J Bone Joint Surg Am 2006, 88:2502–2520.

    Article  PubMed  Google Scholar 

  25. Meisel HJ, Siodla V, Ganey T, et al.: Clinical experience in cell-based therapeutics: disc chondrocyte transplantation A treatment for degenerated or damaged intervertebral disc. Biomol Eng 2007, 24:5–21.

    Article  CAS  PubMed  Google Scholar 

  26. Meisel HJ, Ganey T, Hutton WC, et al.: Clinical experience in cell-based therapeutics: intervention and outcome. Eur Spine J 2006, 15(Suppl 3):S397–S405.

    Article  PubMed  Google Scholar 

  27. Stockwell RA: The interrelationship of cell density and cartilage thickness in mammalian articular cartilage. J Anat 1971, 109:411–421.

    CAS  PubMed  Google Scholar 

  28. Maroudas A, Stockwell RA, Nachemson A, Urban J: Factors involved in the nutrition of the human lumbar intervertebral disc: cellularity and diffusion of glucose in vitro. J Anat 1975, 120:113–130.

    CAS  PubMed  Google Scholar 

  29. Jones E, McGonagle D: Human bone marrow mesenchymal stem cells in vivo. Rheumatology (Oxford) 2008, 47:126–131.

    Article  CAS  Google Scholar 

  30. Urban JP, Smith S, Fairbank JC: Nutrition of the intervertebral disc. Spine 2004, 29:2700–2709.

    Article  PubMed  Google Scholar 

  31. Richardson SM, Walker RV, Parker S, et al.: Intervertebral disc cell-mediated mesenchymal stem cell differentiation. Stem Cells 2006, 24:707–716.

    Article  CAS  PubMed  Google Scholar 

  32. Horner HA, Roberts S, Bielby RC, et al.: Cells from different regions of the intervertebral disc: effect of culture system on matrix expression and cell phenotype. Spine 2002, 27:1018–1028.

    Article  PubMed  Google Scholar 

  33. Ma HL, Hung SC, Lin SY, et al.: Chondrogenesis of human mesenchymal stem cells encapsulated in alginate beads. J Biomed Mater Res A 2003, 64:273–281.

    Article  PubMed  Google Scholar 

  34. Richardson SM, Curran JM, Chen R, et al.: The differentiation of bone marrow mesenchymal stem cells into chondrocyte-like cells on poly-L-lactic acid (PLLA) scaffolds. Biomaterials 2006, 27:4069–4078.

    Article  CAS  PubMed  Google Scholar 

  35. Seguin CA, Grynpas MD, Pilliar RM, et al.: Tissue engineered nucleus pulposus tissue formed on a porous calcium polyphosphate substrate. Spine 2004, 29:1299–1306.

    Article  PubMed  Google Scholar 

  36. Alini M, Li W, Markovic P, et al.: The potential and limitations of a cell-seeded collagen/hyaluronan scaffold to engineer an intervertebral disc-like matrix. Spine 2003, 28:446–454.

    Article  PubMed  Google Scholar 

  37. Richardson SM, Hughes N, Hunt JA, et al.: Human mesenchymal stem cell differentiation to NP-like cells in chitosan-glycerophosphate hydrogels. Biomaterials 2008, 29:85–93.

    Article  CAS  PubMed  Google Scholar 

  38. Sakai D, Mochida J, Iwashina T, et al.: Regenerative effects of transplanting mesenchymal stem cells embedded in atelocollagen to the degenerated intervertebral disc. Biomaterials 2006, 27:335–345.

    Article  CAS  PubMed  Google Scholar 

  39. Risbud MV, Albert TJ, Guttapalli A, et al.: Differentiation of mesenchymal stem cells towards a nucleus pulposus-like phenotype in vitro: implications for cell-based transplantation therapy. Spine 2004, 29:2627–2632.

    Article  PubMed  Google Scholar 

  40. Longobardi L, O’Rear L, Aakula S, et al.: Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res 2006, 21:626–636.

    Article  CAS  PubMed  Google Scholar 

  41. Bai X, Xiao Z, Pan Y, et al.: Cartilage-derived morphogenetic protein-1 promotes the differentiation of mesenchymal stem cells into chondrocytes. Biochem Biophys Res Commun 2004, 325:453–460.

    Article  CAS  PubMed  Google Scholar 

  42. Mauck RL, Byers BA, Yuan X, Tuan RS: Regulation of cartilaginous ECM gene transcription by chondrocytes and MSCs in 3D culture in response to dynamic loading. Biomech Model Mechanobiol 2007, 6:113–125.

    Article  CAS  PubMed  Google Scholar 

  43. Rajpurohit R, Risbud MV, Ducheyne P, et al.: Phenotypic characteristics of the nucleus pulposus: expression of hypoxia inducing factor-1, glucose transporter-1 and MMP-2. Cell Tissue Res 2002, 308:401–407.

    Article  CAS  PubMed  Google Scholar 

  44. Lee CR, Sakai D, Nakai T, et al.: A phenotypic comparison of intervertebral disc and articular cartilage cells in the rat. Eur Spine J 2007, 16:2174–2185.

    Article  PubMed  Google Scholar 

  45. Le Maitre CL, Hoyland JA, Freemont AJ: Studies of human intervertebral disc cell function in a constrained in vitro tissue culture system. Spine 2004, 29:1187–1195.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen M. Richardson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Richardson, S.M., Hoyland, J.A. Stem cell regeneration of degenerated intervertebral discs: Current status. Current Science Inc 12, 83–88 (2008). https://doi.org/10.1007/s11916-008-0016-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-008-0016-3

Keywords

Navigation